UK Markets closed

Poxel S.A. (PXXLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
6.700.00 (0.00%)
At close: 01:57PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.70
Open6.70
Bid0.00 x 0
Ask0.00 x 0
Day's range6.70 - 6.70
52-week range6.03 - 11.25
Volume65
Avg. volume2
Market cap168.074M
Beta (5Y monthly)1.56
PE ratio (TTM)N/A
EPS (TTM)-1.38
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in November

    LYON, France, November 03, 2021--POXEL SA (Euronext – POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders, today announced its participation at upcoming investor and scientific conferences in November 2021.

  • Business Wire

    Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2021

    LYON, France, October 20, 2021--POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders, today provided a corporate update and announced its cash position and revenue for the third quarter and the nine months ended September 30, 2021.

  • Zacks

    What Makes POXEL SA FRANCE (PXXLF) a New Buy Stock

    POXEL SA FRANCE (PXXLF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).